Targets and intracellular signaling mechanisms for deoxynivalenol-induced ribosomal RNA cleavage.
Targets and intracellular signaling mechanisms for deoxynivalenol-induced ribosomal RNA cleavage.
复制标题
DOI:
10.1093/toxsci/kfs134
复制
发表时间:
2012-06
期刊:
影响因子:
--
通讯作者:
Pestka JJ
中科院分区:
文献类型:
--
作者:
He K;Zhou HR;Pestka JJ
The trichothecene mycotoxin deoxynivalenol (DON), a known translational inhibitor, induces ribosomal RNA (rRNA) cleavage. Here, we characterized this process relative to (1) specific 18S and 28S ribosomal RNA cleavage sites and (2) identity of specific upstream signaling elements in this pathway. Capillary electrophoresis indicated that DON at concentrations as low as 200 ng/ml evoked selective rRNA cleavage after 6 h and that 1000 ng/ml caused cleavage within 2 h. Northern blot analysis revealed that DON exposure induced six rRNA cleavage fragments from 28S rRNA and five fragments from 18S rRNA. When selective kinase inhibitors were used to identify potential upstream signals, RNA-activated protein kinase (PKR), hematopoietic cell kinase (Hck), and p38 were found to be required for rRNA cleavage, whereas c-Jun N-terminal kinase and extracellular signal-regulated kinase were not. Furthermore, rRNA fragmentation was suppressed by the p53 inhibitors pifithrin-α and pifithrin-μ as well as the pan caspase inhibitor Z-VAD-FMK. Concurrent apoptosis was confirmed by acridine orange/ethidium bromide staining and flow cytometry. DON activated caspases 3, 8, and 9, thus suggesting the possible coinvolvement of both extrinsic and intrinsic apoptotic pathways in rRNA cleavage. Satratoxin G (SG), anisomycin, and ricin also induced specific rRNA cleavage profiles identical to those of DON, suggesting that ribotoxins might share a conserved rRNA cleavage mechanism. Taken together, DON-induced rRNA cleavage is likely to be closely linked to apoptosis activation and appears to involve the sequential activation of PKR/Hck →p38→p53→caspase 8/9→caspase 3.
登录
查看更多内容
DOI:
10.1084/jem.20020873
发表时间:
2002-09-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ernst M;Inglese M;Scholz GM;Harder KW;Clay FJ;Bozinovski S;Waring P;Darwiche R;Kay T;Sly P;Collins R;Turner D;Hibbs ML;Anderson GP;Dunn AR
通讯作者:
Dunn AR
影响因子:
11.4
作者:
Bulavin, DV;Saito, S;Fornace, AJ
通讯作者:
Fornace, AJ
影响因子:
3.5
作者:
HOUGE, G;DOSKELAND, SO;LANOTTE, M
通讯作者:
LANOTTE, M
DOI:
10.1080/19440049.2010.551301
发表时间:
2012-01-01
影响因子:
2.9
作者:
Hepworth, S. J.;Hardie, L. J.;Turner, P. C.
通讯作者:
Turner, P. C.
影响因子:
3.8
作者:
Chung, YJ;Zhou, HR;Pestka, JJ
通讯作者:
Pestka, JJ